Notes to the Accounts (continued)

29. Funding committee members receiving grants (continued) Of the scientists above, those who headed projects that received grant awards in excess of £1 million in the year are:

£000

Paterson Institute for Cancer Research Nic Jones University of Oxford

Imperial College London

Queen Mary, University of London Imperial College London

The Institute of Cancer Research University of Edinburgh

The University of Birmingham The Institute of Cancer Research University of Cambridge

Gillies William McKenna

Raoul Charles Dalmedo Coombes Kairbaan Hodivala-Dilke Eric O Aboagye Martin O Leach

Malcolm G Dunlop Philip J Johnson David Barford Jonathon Pines

11,712 3,987 2,390 1,954 1,815 1,784 1,524 1,368 1,352 1,077

Scientists who serve on the Group’s grant-making committees may not participate in any decisions that relate to funding either of research projects where they have an interest or of their institutions.

Professor Peter Johnson, Chief Clinician, is a member of both the Charity’s Executive and Scientific Executive Boards.

Professor Nic Jones, Chief Scientist, is a member of both the Charity’s Executive and Scientific Executive Boards and is also a fellow of the Gibb Research Fellowship Endowment Fund.

30. Pensions Cancer Research UK operates a defined benefit pension scheme and defined contribution pension schemes. The defined benefit pension scheme closed to new members on 31 December 2009.

a) Pension scheme accounted for as a defined benefit scheme The contributions paid to the Cancer Research UK Pension Scheme are in accordance with the rates agreed following the 31 March 2009 actuarial valuation.

In relation to all members and new entrants, the Group has contributed, as a percentage of members’ salaries, at the following rates:

To 30 April 2010

1 May 2010 to 31 December 2010 From 1 January 2011

Rate contributed 20.1%

19.1% 19.1% - 26.1%

In addition the Group contributed 2.4% of salaries for ‘Stakeholder members’ and 0.2% of salaries for members covered for lump sum death in service benefits only.

The Group expects to pay contributions of £20.0 million for the year to 31 March 2012 (contributions actually paid in the year to 31 March 2011 were £17.6 million).

As required by FRS17, the defined benefit liabilities have been measured using the projected unit method. The tables over the page state the FRS17 actuarial assumptions upon which the valuation of the scheme was based.

54 / Annual Report and Accounts / Notes to the Accounts